Inflammatory pathway enzyme

The term "Inflammatory pathway enzymes" is a broad category that refers collectively to multiple enzymes involved in the initiation, propagation, or resolution of inflammation. These include but are not limited to cyclooxygenases (COX), lipoxygenases such as 5-lipoxygenase (5‑LOX), inducible nitric oxide synthase (iNOS), NADPH oxidases, superoxide dismutases, glutathione peroxidases, and others. These enzymes regulate the production of key inflammatory mediators like prostaglandins and leukotrienes or modulate oxidative stress during immune responses. Abnormal activation or dysregulation can contribute to chronic inflammatory diseases including cardiovascular disease and cancer[1][7]. Many anti-inflammatory drugs act by inhibiting these enzymatic pathways—NSAIDs inhibit COX isoforms while leukotriene inhibitors target LOX pathways[7][9]. However, "Inflammatory pathway enzymes" is not a canonical name for any single molecular target but rather an umbrella term encompassing several distinct proteins with diverse functions. Note: The entry "Inflammatory pathway enzymes" is too generic for structured data mapping—it does not refer to one specific molecule but rather a class/family comprising many different targets with unique properties. For precise information retrieval or drug development purposes it is necessary to specify the exact enzyme(s) within this group—such as "Cyclooxygenase‑2," "Inducible nitric oxide synthase," etc.[1][7]

Other names

Inflammation-related enzymePro-inflammatory enzymeAnti-inflammatory enzyme (generic terms; not specific to a single molecule)

Enzyme inhibition to reduce synthesis of pro-inflammatory mediators[9][7]